DOI:
10.1055/s-00000094
Zeitschrift für Gastroenterologie
LinksClose Window
References
Conroy T. et al.
Definitive chemoradiotherapy with FOLFOX versus fluorouracil and cisplatin in patients with oesophageal cancer (PRODIGE5/ACCORD17): final results of a randomised, phase 2/3 trial.
Lancet Oncol 2014;
15: 305-314
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.